The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral adiposity, and age in women

The Journal of Clinical Endocrinology and Metabolism
Alice S Ryan, D Elahi

Abstract

The acute effects of hyperglycemia and hyperinsulinemia on plasma leptin levels were determined in 42 highly trained women athletes (18-69 yr) and 14 sedentary control women (18-50 yr, body mass index < 25 kg/m2), using the glucose clamp technique. The relationships of body composition, physical fitness, age, and plasma leptin levels were examined in all participants. In addition, the effect of weight loss and aerobic exercise and plasma leptin levels were examined in 4 Newly diagnosed untreated noninsulin-dependent diabetes mellitus patients. The time course of plasma leptin levels changed little from basal during hyperglycemic (approximately 10 mmol/L) or hyperinsulinemic-euglycemic (400-3000 pmol/L) clamp studies in either athletes, controls, or noninsulin-dependent diabetes mellitus patients. A strong correlation between plasma leptin levels and fasting insulin was present (r = 0.60, P < 0.001). Plasma leptin and percent fat were higher in controls than athletes (12.6 vs. 4.0 ng/mL and 33.2 vs. 20.8%; both P < 0.001). The relationships between percent fat (dual-energy x-ray absorptiometry) or intraabdominal adipose tissue (computed tomography) and leptin for the entire group were highly significant (r = 0.70, r = 0.52; P < ...Continue Reading

Citations

Sep 1, 1997·The Journal of Clinical Investigation·G BodenM Polansky
May 29, 2014·World Journal of Surgery·Rania Abdel RehemTarek Ezzat Abdel-Aziz
Jan 12, 2008·Obesity Surgery·José M OlmosJesús González Macías
Feb 24, 2006·European Journal of Internal Medicine·Ingrid M JazetA Edo Meinders
Nov 14, 2002·Obesity Research·Harald StinglMichael Roden
Jul 23, 1998·Australian and New Zealand Journal of Medicine·R W Taylor, A Goulding
Apr 13, 2001·Journal of the American Geriatrics Society·A S RyanA P Goldberg
Oct 18, 2002·Journal of the American Geriatrics Society·Michi YukawaDavid S Weigle
Mar 7, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A S RyanA P Goldberg
Dec 29, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·M J SoaresG R Collier
Mar 16, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J KobayashiM Shinomiya
Oct 18, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·N F ChuE B Rimm
Aug 15, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·A S RyanD Elahi
Jul 17, 2004·Journal of Atherosclerosis and Thrombosis·Junji KobayashiMitsuyo Watanabe
Jun 1, 1997·The Journal of Clinical Endocrinology and Metabolism·G A LaughlinS S Yen
Dec 22, 1999·The Journal of Clinical Endocrinology and Metabolism·E H HathoutM F Saad
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·J S FisherW M Kohrt
Oct 24, 1998·Clinical Physiology·G FrühbeckA M Prentice
Mar 27, 1999·European Journal of Clinical Investigation·B Eliasson, U Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.